JP2024503976A5 - - Google Patents
Info
- Publication number
- JP2024503976A5 JP2024503976A5 JP2023534653A JP2023534653A JP2024503976A5 JP 2024503976 A5 JP2024503976 A5 JP 2024503976A5 JP 2023534653 A JP2023534653 A JP 2023534653A JP 2023534653 A JP2023534653 A JP 2023534653A JP 2024503976 A5 JP2024503976 A5 JP 2024503976A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- cells
- independently
- sulfur
- nitrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063128682P | 2020-12-21 | 2020-12-21 | |
| US63/128,682 | 2020-12-21 | ||
| PCT/US2021/064312 WO2022140238A1 (en) | 2020-12-21 | 2021-12-20 | Nanomaterials comprising acetals |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024503976A JP2024503976A (ja) | 2024-01-30 |
| JP2024503976A5 true JP2024503976A5 (enExample) | 2024-12-27 |
Family
ID=82158389
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023534653A Pending JP2024503976A (ja) | 2020-12-21 | 2021-12-20 | アセタールを含むナノ材料 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230331656A1 (enExample) |
| EP (1) | EP4262817A4 (enExample) |
| JP (1) | JP2024503976A (enExample) |
| CN (1) | CN116782913A (enExample) |
| AU (1) | AU2021409377A1 (enExample) |
| CA (1) | CA3203457A1 (enExample) |
| WO (1) | WO2022140238A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3145913A1 (en) | 2019-07-29 | 2021-02-04 | James Everett Dahlman | Nanomaterials containing constrained lipids and uses thereof |
| IL294318A (en) | 2020-01-09 | 2022-08-01 | Guide Therapeutics Llc | Nanomaterials |
| EP4281080A4 (en) | 2021-01-20 | 2025-09-24 | Beam Therapeutics Inc | NANOMATERIALS COMPRISING A BIODEGRADABLE ELEMENT |
| CN116761888A (zh) | 2021-01-20 | 2023-09-15 | 比姆医疗股份有限公司 | 纳米材料 |
| CA3260437A1 (en) | 2022-07-20 | 2024-01-25 | Beam Therapeutics Inc. | NANOMATERIALS INCLUDING TRIOLS |
| AU2024279278A1 (en) | 2023-05-31 | 2025-12-18 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3622993A1 (de) * | 1986-07-09 | 1988-01-21 | Behringwerke Ag | Dispersionspolymere, biologisch aktive dispersionspolymere, verfahren zu ihrer herstellung und verwendung als diagnostisches mittel |
| DE19940641A1 (de) * | 1999-08-26 | 2001-03-01 | Basf Ag | Verfahren zur Herstellung von 4-Acyl-aminosäureestern und N-Acyl-Aminoacetalen |
| US20080039531A1 (en) * | 2005-06-13 | 2008-02-14 | Alfred Stracher | Compositions, and kits comprising targeted aldehyde or acetal protease inhibitor compounds for treating muscle disorders |
| JP5422357B2 (ja) * | 2008-12-12 | 2014-02-19 | 富士フイルム株式会社 | 感活性光線性又は感放射線性樹脂組成物、及びそれを用いたパターン形成方法 |
| US20220009878A1 (en) * | 2018-10-02 | 2022-01-13 | Intellia Therapeutics, Inc. | Ionizable amine lipids |
| CN114127044A (zh) * | 2019-04-25 | 2022-03-01 | 英特利亚治疗股份有限公司 | 可电离的胺类脂质和脂质纳米颗粒 |
| EP4262819A4 (en) * | 2020-12-21 | 2024-12-04 | Beam Therapeutics Inc. | NANOMATERIALS WITH ESTER-BOUND ACETALS |
-
2021
- 2021-12-20 JP JP2023534653A patent/JP2024503976A/ja active Pending
- 2021-12-20 EP EP21911963.3A patent/EP4262817A4/en active Pending
- 2021-12-20 WO PCT/US2021/064312 patent/WO2022140238A1/en not_active Ceased
- 2021-12-20 AU AU2021409377A patent/AU2021409377A1/en active Pending
- 2021-12-20 CA CA3203457A patent/CA3203457A1/en active Pending
- 2021-12-20 CN CN202180084663.4A patent/CN116782913A/zh active Pending
-
2023
- 2023-06-20 US US18/211,822 patent/US20230331656A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024508347A5 (enExample) | ||
| JP2024503976A5 (enExample) | ||
| TWI789695B (zh) | 治療sars cov-2感染之方法 | |
| JP6875454B2 (ja) | Ｈｉｖを治療するためのトール様受容体の調節因子 | |
| TWI687415B (zh) | Hiv蛋白質膜抑制劑之固體形式 | |
| TWI664966B (zh) | 治療性化合物 | |
| JP2021178873A (ja) | Ｈｉｖカプシド阻害剤のコリン塩形態 | |
| KR102934440B1 (ko) | 가교된 트리사이클릭 카르바모일피리돈 화합물 및 이의 용도 | |
| US20200345699A1 (en) | Hiv protease inhibitors | |
| TWI867455B (zh) | 用於治療病毒感染的化合物及方法 | |
| CN112423750A (zh) | 用于治疗hiv的衣壳抑制剂 | |
| TWI714820B (zh) | 替諾福韋艾拉酚胺(tenofovir alafenamide)之晶型 | |
| JP2025501731A5 (enExample) | ||
| JP2024542755A5 (enExample) | ||
| JP2024542541A5 (enExample) | ||
| JP2026501044A (ja) | 医薬製剤及びその使用 | |
| JP2025032127A (ja) | ピロロピリミジン化合物の治療的使用およびその固形医薬組成物 | |
| JP2002517443A (ja) | Ｈｉｖプロテアーゼ阻害剤の浸透を増加させる方法および組成物 | |
| WO2023070058A1 (en) | Treatment of viruses with antiviral nucleosides | |
| CN118786128A (zh) | 用于治疗病毒感染的化合物和方法 | |
| JP4380967B2 (ja) | ウイルス性心筋炎の予防または治療剤 | |
| JP7127817B2 (ja) | 肺高血圧治療薬 | |
| HK40092944B (zh) | 桥连三环氨基甲酰基吡啶酮化合物及其用途 | |
| HK40092944A (zh) | 桥连三环氨基甲酰基吡啶酮化合物及其用途 | |
| HK40113783A (zh) | 用於治疗病毒感染的化合物和方法 |